Position in GANX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$920,607
+$52,765 QoQ
Shares Held
453,501
+1.4% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 49 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,415,676 across 520 Biotechnology names. GANX ranks #322 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in GANX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $920,607 | 453,501 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $867,842 | 447,342 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,281,373 | 397,942 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $609,137 | 344,146 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $522,831 | 290,462 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $539,022 | 282,211 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $577,629 | 267,421 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $484,109 | 271,972 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $235,181 | 183,736 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $667,633 | 177,091 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $494,569 | 151,476 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $496,841 | 151,476 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $621,470 | 138,721 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $454,077 | 94,207 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $282,056 | 90,114 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $286,772 | 87,967 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $92,944 | 25,818 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $104,818 | 25,628 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $108,904 | 20,056 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||